197 related articles for article (PubMed ID: 22112875)
1. Medical management trumps stenting for intracranial arterial stenosis.
Rosenberg K
Am J Nurs; 2011 Dec; 111(12):16. PubMed ID: 22112875
[No Abstract] [Full Text] [Related]
2. Platelets and stents.
Nemergut EC; Shaffrey ME
J Neurosurg; 2007 Oct; 107(4):900-2; author reply 902. PubMed ID: 17937245
[No Abstract] [Full Text] [Related]
3. Treatment of intracranial atherosclerotic stenosis.
Turan TN; Chimowitz MI
Rev Neurol Dis; 2008; 5(3):117-24. PubMed ID: 18838951
[TBL] [Abstract][Full Text] [Related]
4. Stenting versus aggressive medical therapy for intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Derdeyn CP; Turan TN; Fiorella D; Lane BF; Janis LS; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Torbey MT; Zaidat OO; Rumboldt Z; Cloft HJ;
N Engl J Med; 2011 Sep; 365(11):993-1003. PubMed ID: 21899409
[TBL] [Abstract][Full Text] [Related]
5. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
6. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
Turan TN; Cotsonis G; Lynn MJ; Wooley RH; Swanson S; Williams JE; Stern BJ; Derdeyn CP; Fiorella D; Chimowitz MI
Cerebrovasc Dis; 2014; 37(3):203-11. PubMed ID: 24557055
[TBL] [Abstract][Full Text] [Related]
7. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.
Derdeyn CP; Chimowitz MI
Neuroimaging Clin N Am; 2007 Aug; 17(3):355-63, viii-ix. PubMed ID: 17826637
[TBL] [Abstract][Full Text] [Related]
8. Durability of endovascular therapy for symptomatic intracranial atherosclerosis.
Mazighi M; Yadav JS; Abou-Chebl A
Stroke; 2008 Jun; 39(6):1766-9. PubMed ID: 18420956
[TBL] [Abstract][Full Text] [Related]
9. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587200
[No Abstract] [Full Text] [Related]
10. Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial.
Leung TW; Yu SC; Wong KS
Int J Stroke; 2011 Aug; 6(4):312-4. PubMed ID: 21745340
[TBL] [Abstract][Full Text] [Related]
11. Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients.
Yu SC; Leung TW; Lee KT; Wong LK
J Neurointerv Surg; 2014 Apr; 6(3):212-8. PubMed ID: 23516268
[TBL] [Abstract][Full Text] [Related]
12. [Clopidogrel protection is not increased further by ASS!].
Bogousslavsky J
Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578
[No Abstract] [Full Text] [Related]
13. Early aggressive medical management for patients with symptomatic intracranial stenosis.
Nahab F; Kingston C; Frankel MR; Dion JE; Cawley CM; Mitchell B; Hammonds LP; Ayala L; Tong FC
J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):87-91. PubMed ID: 21795066
[TBL] [Abstract][Full Text] [Related]
14. SAMMPRIS: end of intracranial stenting for atherosclerosis or back to the drawing board?
Rahme RJ; Aoun SG; Batjer HH; Bendok BR
Neurosurgery; 2011 Dec; 69(6):N16-8. PubMed ID: 22067345
[No Abstract] [Full Text] [Related]
15. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.
Chimowitz MI; Lynn MJ; Turan TN; Fiorella D; Lane BF; Janis S; Derdeyn CP;
J Stroke Cerebrovasc Dis; 2011; 20(4):357-68. PubMed ID: 21729789
[TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
Einecke D
MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366495
[No Abstract] [Full Text] [Related]
17. [Emergency treatment of transient cerebral ischemia].
Boysen G
Ugeskr Laeger; 2008 Apr; 170(17):1475. PubMed ID: 18488296
[No Abstract] [Full Text] [Related]
18. [Clopidogrel as basic therapy in high-risk stroke patients].
Mattle HP
Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
[No Abstract] [Full Text] [Related]
19. Lessons from MATCH for future randomised trials in secondary prevention of stroke.
Rothwell PM
Lancet; 2004 Jul 24-30; 364(9431):305-7. PubMed ID: 15276368
[No Abstract] [Full Text] [Related]
20. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
Moonis M; Fisher M
Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
